We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
This brief considers the main regulatory frameworks and the scope for achieving better access to medicines
Pharmaceutical companies, global health donors and other stakeholders have increasingly recognized the need for a careful analysis.
This Brief presents evidence for health and development benefits from creating stronger linkages between industrial and health agendas
The CMU is part of the Medicine, Pharmacy and Industry Group of DHSC which looks at supply and procurement in hospitals.
This is the 11th report to Parliament on the Pharmaceutical Price Regulation Scheme (PPRS).
Search for information about medicines including patient information leaflets (PILs), details on how the medicine can be used (SmPCs) and scientific reports (PARs).
The Ministerial Industry Strategy Group (MISG) brings together government and the bio-pharmaceutical industry. The purpose of the group is to jointly consider how to promote a strong and profitable UK-based bio-pharmaceutical industry. The group is co-chaired by the Secretary of...
The 2009 PPRS is a five-year voluntary scheme effective from 1 January 2009, agreed between Government and the pharmaceutical industry.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to get scientific advice about your licence application from MHRA, including: submitting a request, your meeting with MHRA, fees.
How to use PharmaQC to access pharmaceutical suppliers, Quality Control (QC) pharmacists and Commercial Medicines Unit (CMU) buyers.
The 12th report updates parliament on the Pharmaceutical Price Regulation Scheme (PPRS).
This brief presents some trends and developments of the Kenyan pharmaceutical industry
Quadrant Pharmaceuticals Ltd has informed the MHRA of an error with the Patient Information Leaflets (PILs) in the listed batches of Cozaar 100mg film-coated tablets.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).